In melanoma, CXCL10–CXCR3 crosstalk drives the proliferation and accumulation of immunosuppressive monocytic myeloid-derived suppressor cells (mo-MDSC) via activation of the p38 MAPK pathway, thereby promoting tumor aggressiveness [123]. Here, CXCR3 is linked to melanoma.